Bio-Rad and 10X Genomics end patent fight with new licensing deal

29-07-2021

Muireann Bolger

Bio-Rad and 10X Genomics end patent fight with new licensing deal

Casimiro PT / Shutterstock.com

Bio-Rad Laboratories has settled its long-running dispute with 10X Genomics over patents covering genetic analysis tech and both companies have negotiated an agreement to cross-license their products.


Bio-Rad, patents, settlement, companies, analysis, single-cell, Federal Circuit, genomics,

LSIPR